Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex
Cells · 07.02.2023 · 12 (4) · 533
DOI: 10.3390/cells12040533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 07.02.2023. Verfasst von Jules Mérian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut des Maladies Métaboliques et Cardiovasculaires, I2MC, Université de Toulouse, Inserm, Université Toulouse III-Paul Sabatier (UPS), UMR1297, …. Hauptthemen laut MEDLINE: Atherosclerosis, Dyslipidemias, Hyperlipidemias, Hypercholesterolemia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: region Occitanie Pyrénées-Méditerranée, Inserm and the Region Occitanie Pyrénées-Méditerranée.
Abstract (Originalsprache)
In humans and animal models, intermittent fasting (IF) interventions promote body weight loss, improve metabolic health, and are thought to lower cardiovascular disease risk. However, there is a paucity of reports on the relevance of such nutritional interventions in the context of dyslipidemia and atherosclerotic cardiovascular diseases. The present study assessed the metabolic and atheroprotective effects of intermittent fasting intervention (IF) in atherosclerosis-prone apolipoprotein E-deficient (Apoe-/-) mice. Groups of male and female Apoe-/- mice were fed a regular (chow) or atherogenic (high-fat, high-cholesterol, HFCD) diet for 4 months, either ad libitum or in an alternate-day fasting manner. The results show that IF intervention improved glucose and lipid metabolism independently of sex. However, IF only decreased body weight gain in males fed chow diet and differentially modulated adipose tissue parameters and liver steatosis in a diet composition-dependent manner. Finally, IF prevented spontaneous aortic atherosclerotic lesion formation in mice fed chow diet, irrespective of sex, but failed to reduce HFCD-diet-induced atherosclerosis. Overall, the current work indicates that IF interventions can efficiently improve glucose homeostasis and treat atherogenic dyslipidemia, but a degree of caution is warranted with regard to the individual sex and the composition of the dietary regimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut des Maladies Métaboliques et Cardiovasculaires, I2MC, Université de Toulouse, Inserm, Université Toulouse III-Paul Sabatier (UPS), UMR1297, 31432 Toulouse, France.
- Lifesearch SAS, 195 Route d'Espagne, 31100 Toulouse, France.
ORCID-Profile: Diane Beuzelin, Laurent O Martinez
Förderung
- region Occitanie Pyrénées-Méditerranée
- Inserm and the Region Occitanie Pyrénées-Méditerranée
Zitieren
APA
Mérian, J., Ghezali, L., Trenteseaux, C., Duparc, T., Beuzelin, D., Bouguetoch, V., Combes, G., Sioufi, N., Martinez, L. O., & Najib, S. (2023). Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex. Cells, 12(4), 533. https://doi.org/10.3390/cells12040533
Vancouver
Mérian J, Ghezali L, Trenteseaux C, Duparc T, Beuzelin D, Bouguetoch V, et al. Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex. Cells. 2023;12(4):533. doi:10.3390/cells12040533
BibTeX
@article{Mrian2023,
author = {Mérian, Jules and Ghezali, Lamia and Trenteseaux, Charlotte and Duparc, Thibaut and Beuzelin, Diane and Bouguetoch, Vanessa and Combes, Guillaume and Sioufi, Nabil and Martinez, Laurent O and Najib, Souad},
title = {Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex},
journal = {Cells},
year = {2023},
volume = {12},
number = {4},
pages = {533},
doi = {10.3390/cells12040533}
}
EUVIMED